These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 27930980

  • 1. Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylation in diabetic rats.
    Elseweidy MM, Amin RS, Atteia HH, Ali MA.
    Biomed Pharmacother; 2017 Jan; 85():155-159. PubMed ID: 27930980
    [Abstract] [Full Text] [Related]

  • 2. Nigella sativa Oil and Chromium Picolinate Ameliorate Fructose-Induced Hyperinsulinemia by Enhancing Insulin Signaling and Suppressing Insulin-Degrading Enzyme in Male Rats.
    Elseweidy MM, Amin RS, Atteia HH, Aly MA.
    Biol Trace Elem Res; 2018 Jul; 184(1):119-126. PubMed ID: 28975521
    [Abstract] [Full Text] [Related]

  • 3. Reduced insulin clearance and lower insulin-degrading enzyme expression in the liver might contribute to the thrifty phenotype of protein-restricted mice.
    Rezende LF, Camargo RL, Branco RC, Cappelli AP, Boschero AC, Carneiro EM.
    Br J Nutr; 2014 Sep 28; 112(6):900-7. PubMed ID: 25036874
    [Abstract] [Full Text] [Related]

  • 4. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S.
    Proc Natl Acad Sci U S A; 2003 Apr 01; 100(7):4162-7. PubMed ID: 12634421
    [Abstract] [Full Text] [Related]

  • 5. Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme.
    Protzek AO, Rezende LF, Costa-Júnior JM, Ferreira SM, Cappelli AP, de Paula FM, de Souza JC, Kurauti MA, Carneiro EM, Rafacho A, Boschero AC.
    J Steroid Biochem Mol Biol; 2016 Jan 01; 155(Pt A):1-8. PubMed ID: 26386462
    [Abstract] [Full Text] [Related]

  • 6. Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues.
    Kochkina EG, Plesneva SA, Vasilev DS, Zhuravin IA, Turner AJ, Nalivaeva NN.
    Biogerontology; 2015 Aug 01; 16(4):473-84. PubMed ID: 25792373
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D3 restores altered cholinergic and insulin receptor expression in the cerebral cortex and muscarinic M3 receptor expression in pancreatic islets of streptozotocin induced diabetic rats.
    Kumar PT, Antony S, Nandhu MS, Sadanandan J, Naijil G, Paulose CS.
    J Nutr Biochem; 2011 May 01; 22(5):418-25. PubMed ID: 20655720
    [Abstract] [Full Text] [Related]

  • 8. Cholinergic, dopaminergic and insulin receptors gene expression in the cerebellum of streptozotocin-induced diabetic rats: functional regulation with Vitamin D3 supplementation.
    Peeyush KT, Savitha B, Sherin A, Anju TR, Jes P, Paulose CS.
    Pharmacol Biochem Behav; 2010 Apr 01; 95(2):216-22. PubMed ID: 20096724
    [Abstract] [Full Text] [Related]

  • 9. Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme.
    Authier F, Rachubinski RA, Posner BI, Bergeron JJ.
    J Biol Chem; 1994 Jan 28; 269(4):3010-6. PubMed ID: 8300632
    [Abstract] [Full Text] [Related]

  • 10. Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia.
    Bernstein HG, Ernst T, Lendeckel U, Bukowska A, Ansorge S, Stauch R, Have ST, Steiner J, Dobrowolny H, Bogerts B.
    J Psychiatr Res; 2009 Sep 28; 43(13):1095-105. PubMed ID: 19394958
    [Abstract] [Full Text] [Related]

  • 11. Degradation of amylin by insulin-degrading enzyme.
    Bennett RG, Duckworth WC, Hamel FG.
    J Biol Chem; 2000 Nov 24; 275(47):36621-5. PubMed ID: 10973971
    [Abstract] [Full Text] [Related]

  • 12. Effect of vitamin D3 on thyroid function and de-iodinase 2 expression in diabetic rats.
    Alrefaie Z, Awad H.
    Arch Physiol Biochem; 2015 Nov 24; 121(5):206-9. PubMed ID: 26599099
    [Abstract] [Full Text] [Related]

  • 13. Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues.
    Kulas JA, Franklin WF, Smith NA, Manocha GD, Puig KL, Nagamoto-Combs K, Hendrix RD, Taglialatela G, Barger SW, Combs CK.
    Am J Physiol Endocrinol Metab; 2019 Jan 01; 316(1):E106-E120. PubMed ID: 30422705
    [Abstract] [Full Text] [Related]

  • 14. Metabolism of a mutant insulin by a receptor-mediated process and an insulin degrading enzyme.
    Kobayashi M, Iwasaki M, Watanabe N, Ishibashi O, Takata Y, Haruta T, Sasaoka T, Shigeta Y, Inouye K.
    Diabetes Res Clin Pract; 1986 Jan 01; 2(5):257-62. PubMed ID: 3536368
    [Abstract] [Full Text] [Related]

  • 15. [Kinetic studies of insulin degrading enzyme in cultured human lymphocytes].
    Yaso S.
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr 20; 64(4):289-302. PubMed ID: 3042472
    [Abstract] [Full Text] [Related]

  • 16. Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice.
    Villa-Pérez P, Merino B, Fernández-Díaz CM, Cidad P, Lobatón CD, Moreno A, Muturi HT, Ghadieh HE, Najjar SM, Leissring MA, Cózar-Castellano I, Perdomo G.
    Metabolism; 2018 Nov 20; 88():1-11. PubMed ID: 30098324
    [Abstract] [Full Text] [Related]

  • 17. Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues.
    Kuo WL, Montag AG, Rosner MR.
    Endocrinology; 1993 Feb 20; 132(2):604-11. PubMed ID: 7678795
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-6 increases the expression and activity of insulin-degrading enzyme.
    Kurauti MA, Costa-Júnior JM, Ferreira SM, Santos GJ, Sponton CHG, Carneiro EM, Telles GD, Chacon-Mikahil MPT, Cavaglieri CR, Rezende LF, Boschero AC.
    Sci Rep; 2017 Apr 21; 7():46750. PubMed ID: 28429777
    [Abstract] [Full Text] [Related]

  • 19. Modulation of insulin degrading enzyme activity and liver cell proliferation.
    Pivovarova O, von Loeffelholz C, Ilkavets I, Sticht C, Zhuk S, Murahovschi V, Lukowski S, Döcke S, Kriebel J, de las Heras Gala T, Malashicheva A, Kostareva A, Lock JF, Stockmann M, Grallert H, Gretz N, Dooley S, Pfeiffer AF, Rudovich N.
    Cell Cycle; 2015 Apr 21; 14(14):2293-300. PubMed ID: 25945652
    [Abstract] [Full Text] [Related]

  • 20. Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance.
    Abdul-Hay SO, Kang D, McBride M, Li L, Zhao J, Leissring MA.
    PLoS One; 2011 Apr 21; 6(6):e20818. PubMed ID: 21695259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.